• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高强度失语症干预在慢性失语症中几乎不会引起疲劳:一项来自大型随机对照试验的参与者自我评估分析。

High-Intensity Aphasia Intervention Is Minimally Fatiguing in Chronic Aphasia: An Analysis of Participant Self-Ratings From a Large Randomized Controlled Trial.

机构信息

Centre of Research Excellence in Aphasia Recovery and Rehabilitation (J.E.P., L.N., M.H., A.M.F., M.C., C.W., M.L.R., S.H., L.T., E.G., D.A.C., D.C.), Melbourne, VIC, Australia.

La Trobe University, and School of Allied Health, Human Services and Sport (A.M.F., J.E.P., M.L.R., M.C., C.W.), Melbourne, VIC, Australia.

出版信息

Stroke. 2024 Jul;55(7):1877-1885. doi: 10.1161/STROKEAHA.123.046031. Epub 2024 Jun 5.

DOI:10.1161/STROKEAHA.123.046031
PMID:38836352
Abstract

BACKGROUND

High-intensity therapy is recommended in current treatment guidelines for chronic poststroke aphasia. Yet, little is known about fatigue levels induced by treatment, which could interfere with rehabilitation outcomes. We analyzed fatigue experienced by people with chronic aphasia (>6 months) during high-dose interventions at 2 intensities.

METHODS

A retrospective observational analysis was conducted on self-rated fatigue levels of people with chronic aphasia (N=173) collected during a previously published large randomized controlled trial of 2 treatments: constraint-induced aphasia therapy plus and multi-modality aphasia therapy. Interventions were administered at a higher intensity (30 hours over 2 weeks) or lower intensity (30 hours over 5 weeks). Participants rated their fatigue on an 11-point scale before and after each day of therapy. Data were analyzed using Bayesian ordinal multilevel models. Specifically, we considered changes in self-rated participant fatigue across a therapy day and over the intervention period.

RESULTS

Data from 144 participants was analyzed. Participants were English speakers from Australia or New Zealand (mean age, 62 [range, 18-88] years) with 102 men and 42 women. Most had mild (n=115) or moderate (n=52) poststroke aphasia. Median ratings of the level of fatigue by people with aphasia were low (1 on a 0-10-point scale) at the beginning of the day. Ratings increased slightly (+1.0) each day after intervention, with marginally lower increases in the lower intensity schedule. There was no evidence of accumulating fatigue over the 2- or 5-week interventions.

CONCLUSIONS

Findings suggest that intensive intervention was not associated with large increases in fatigue for people with chronic aphasia enrolled in the COMPARE trial (Constraint-Induced or Multimodality Personalised Aphasia Rehabilitation). Fatigue did not change across the course of the intervention. This study provides evidence that intensive treatment was minimally fatiguing for stroke survivors with chronic aphasia, suggesting that fatigue is not a barrier to high-intensity treatment.

摘要

背景

目前的治疗指南建议对慢性卒中后失语症患者进行高强度治疗。然而,对于治疗引起的疲劳程度知之甚少,而这可能会影响康复效果。我们分析了在两种强度下接受高剂量干预的慢性失语症患者(>6 个月)所经历的疲劳程度。

方法

对先前发表的一项关于两种治疗方法的大型随机对照试验(强制性语言治疗+多模态语言治疗)中收集的 173 名慢性失语症患者的自我报告疲劳水平进行了回顾性观察分析。干预措施以较高强度(2 周内 30 小时)或较低强度(5 周内 30 小时)进行。参与者在每天治疗前后使用 11 点量表对疲劳程度进行评分。使用贝叶斯有序多水平模型对数据进行分析。具体来说,我们考虑了治疗日和干预期间参与者自我报告的疲劳变化。

结果

分析了 144 名参与者的数据。参与者为来自澳大利亚或新西兰的英语使用者(平均年龄 62 岁[范围 18-88 岁],102 名男性,42 名女性),其中 115 名患有轻度和 52 名患有中度卒中后失语症。大多数人在治疗开始时的疲劳水平评分较低(0-10 分制的 1 分)。干预后每天略有增加(增加 1.0),低强度方案的增加幅度略低。在 2 或 5 周的干预过程中,没有证据表明疲劳程度逐渐增加。

结论

研究结果表明,对于参加 COMPARE 试验(强制性或多模态个性化失语症康复)的慢性失语症患者,高强度干预与疲劳程度的大幅增加无关。在干预过程中,疲劳程度没有变化。这项研究为高强度治疗对慢性失语症卒中幸存者的疲劳程度影响较小提供了证据,表明疲劳不是高强度治疗的障碍。

相似文献

1
High-Intensity Aphasia Intervention Is Minimally Fatiguing in Chronic Aphasia: An Analysis of Participant Self-Ratings From a Large Randomized Controlled Trial.高强度失语症干预在慢性失语症中几乎不会引起疲劳:一项来自大型随机对照试验的参与者自我评估分析。
Stroke. 2024 Jul;55(7):1877-1885. doi: 10.1161/STROKEAHA.123.046031. Epub 2024 Jun 5.
2
Activity monitors for increasing physical activity in adult stroke survivors.用于增加成年中风幸存者身体活动量的活动监测器。
Cochrane Database Syst Rev. 2018 Jul 27;7(7):CD012543. doi: 10.1002/14651858.CD012543.pub2.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Educational interventions for the management of cancer-related fatigue in adults.针对成人癌症相关疲劳管理的教育干预措施。
Cochrane Database Syst Rev. 2016 Nov 24;11(11):CD008144. doi: 10.1002/14651858.CD008144.pub2.
5
Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.成人纤维肌痛的经皮电神经刺激(TENS)疗法
Cochrane Database Syst Rev. 2017 Oct 9;10(10):CD012172. doi: 10.1002/14651858.CD012172.pub2.
6
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
7
High-Intensity Aphasia Therapy Is Cost-Effective in People With Poststroke Aphasia: Evidence From the COMPARE Trial.高强度失语症疗法在脑卒中后失语症患者中具有成本效益:来自 COMPARE 试验的证据。
Stroke. 2024 Mar;55(3):705-714. doi: 10.1161/STROKEAHA.123.045183. Epub 2024 Feb 8.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Occupational therapy for cognitive impairment in stroke patients.脑卒中患者认知障碍的作业治疗。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
10
Algorithm-based pain management for people with dementia in nursing homes.基于算法的养老院痴呆患者疼痛管理。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013339. doi: 10.1002/14651858.CD013339.pub2.